Related by context. All words. (Click for frequent words.) 64 Rasenick 64 Subgroup analysis 64 DeKosky 63 tarenflurbil 63 Dr. Pasinetti 63 Iruela Arispe 62 Sacktor 62 Christos Mantzoros 61 Eric Kossoff 61 Hepatotoxicity 61 mGluR2 NAM 61 Dr. Ayalew Tefferi 60 flavopiridol 60 Teriflunomide 60 Redei 60 Dr. Fehlings 60 Cochrane reviewers 60 Lu AA# 60 Teplizumab 60 NMDA receptor antagonists 59 GLYX 59 Buyyounouski 59 Birmaher 59 Li Huei Tsai 59 Gunstad 59 Abou Donia 59 clioquinol 59 ziconotide 59 Marc Weisskopf 59 neuropathologic 59 riociguat 59 Tobinick 59 Kristine Yaffe MD 59 Wischik 59 preclinically 59 infantile colic 59 Auwerx 59 MGd 58 clomipramine 58 Iris Loew Friedrich 58 immunomodulatory agents 58 Bresalier 58 Bengt Winblad 58 midstage clinical 58 Zheng Cui 58 poststroke depression 58 statins cholesterol lowering 58 Abram Hoffer 58 Laheru 58 SGS# 58 EDEMA3 trial 58 Felitti 58 CP CPPS 58 Valdoxan 58 antioxidant supplementation 58 tryptophan depletion 58 Jordan Grafman 58 amyloid cascade 58 Symadex 58 Shamay Tsoory 58 AA Amyloidosis 58 Soffritti 57 Clinical Antipsychotic Trials 57 El Deiry 57 VA# [002] 57 primary Restless Legs 57 Cytolin ® 57 ADAGIO study 57 Blum Cytokinetics 57 neuroimaging studies 57 Amir Lerman 57 Valproic acid 57 samalizumab 57 desvenlafaxine succinate 57 GFT# 57 Singh Manoux 57 Lone Simonsen 57 VADT 57 GAMMAGARD 57 Marbán 57 brivaracetam 57 Ele Ferrannini 57 Gheorghiade 57 visceral metastases 57 Steven B. Ratoff 57 dose proportionality 57 MGUS 57 HQK 57 Karumanchi 57 paricalcitol 57 CHARISMA trial 57 BioNumerik 57 YONDELIS 57 fronto temporal dementia 57 venlafaxine XR 57 GSK# [001] 57 Koenekoop 57 thalidomide Thalomid 57 R#/MEM # 57 LT NS# 57 demonstrated antitumor activity 57 relapsed MM 57 Dr. Sosne 57 multi infarct dementia 57 MAGE A3 ASCI 57 ZOLINZA 57 Cariprazine 57 EOquin TM phase 56 Hotamisligil 56 CRLX# 56 Dr. Tashkin 56 Greengard 56 plasma pharmacokinetics 56 Stephanie Belloc 56 Pier Paolo Pandolfi 56 D Cycloserine 56 impaired insulin secretion 56 pharmacokinetic characteristics 56 Rasagiline 56 mg BID dose 56 Dr. Von Hoff 56 AGTR1 56 antibiotic minocycline 56 darbepoetin alpha 56 MERLIN TIMI 56 Kantarjian 56 Temsirolimus 56 LaFerla 56 Oparil 56 neuronal dysfunction 56 AGILECT R 56 gallium nitrate 56 GRN# 56 renoprotective 56 membranous nephritis 56 antibiotic rifaximin 56 PDE# inhibitors 56 thiopurine 56 BMC Neuroscience 56 MIRAPEX ER 56 ORAL Solo 56 Intervention Effectiveness CATIE 56 radiolabeled TM# 56 Safinamide 56 Ari Melnick 56 LAB CGRP 56 bile acid metabolism 56 neuro protective 56 Shlipak 56 acute mania 56 Arendash 56 dopamine hypothesis 56 trastuzumab Herceptin ® 56 Andrew Leuchter 56 CHARM Added 56 Pimavanserin 56 Tlsty 56 underlying pathophysiology 56 Sherine Gabriel 56 MetAP2 56 Zemiva imaging 56 fluvastatin 56 Dr. Roehrborn 56 donepezil 56 J. Clauw MD 56 Prof. Krainer 56 atypical femur fractures 56 Reverset 56 Tardive dyskinesia 56 neuropsychiatric symptoms 56 ruboxistaurin 56 selenium supplementation 56 Venlafaxine 56 transplanted neural stem 56 Dr. Vitetta 56 biochemical abnormalities 56 behavioral disturbances 56 CXB# 56 Simon LeVay 56 Sudhir Agrawal D.Phil 56 selective modulator 56 Depression Study TADS 56 preclinical pharmacokinetic 56 intravenous immunoglobulin IVIg 56 psoriatic arthritis PsA 56 rufinamide 55 cardiac valvulopathy 55 cardioprotective effects 55 leader Hakon Hakonarson 55 metabolite concentrations 55 Multivariate analyzes 55 pyridostigmine 55 hsCRP levels 55 Werner Hacke 55 Dr. Gurbel 55 compound INCB# 55 Warach 55 Christiane Reitz 55 Dr. Nabel 55 interferon beta therapy 55 fMRI scans 55 pharmacokinetic interactions 55 parkinsonian symptoms 55 Nir Barzilai 55 haloperidol Haldol 55 VaD 55 neurocognitive function 55 circadian rhythm disorders 55 Getzenberg 55 mGluR4 activation 55 Schretlen 55 STEP BD 55 STRIDE PD 55 alkalosis 55 neuroactive 55 visilizumab 55 Brzustowicz 55 Wolf Reik 55 Electroencephalography 55 Paxil paroxetine 55 Alpha synuclein 55 Pasinetti 55 EXJADE 55 5 HT6 receptor 55 pathological hallmark 55 familial aggregation 55 oxysterols 55 somatostatin analog 55 #F FDG PET 55 TCF#L# gene 55 mGluR5 antagonist 55 beta carotene supplementation 55 uridine triacetate 55 hyperprolactinemia 55 Ronald DePinho 55 glatiramer 55 APOE genotype 55 Subgroup analyzes 55 euthymic patients 55 SNT MC# 55 carotid IMT 55 Melov 55 Asher Chanan Khan 55 TACI Ig 55 Silodosin 55 Heterozygous Familial Hypercholesterolemia 55 recurrent glioblastoma multiforme 55 underlying molecular mechanisms 55 oxcarbazepine 55 Riluzole 55 sitaxsentan 55 serum phosphate 55 Hypertensive adverse reactions 55 ImmunoVEX HSV2 55 Carotid Revascularization Endarterectomy vs. 55 immunological responses 55 constipation predominant irritable bowel 55 cannabinor 55 IBMT 55 multitargeted 55 Proellex TM 55 Mayo Clinic hematologist 55 Yosipovitch 55 cMET 55 CIMZIA ™ 55 plasma kallikrein inhibitor 55 GPC5 55 roscovitine 55 Nanette Wenger 55 remyelination 55 akinetic mutism 55 Certolizumab pegol 55 EchoCRT 55 Non inferiority 55 indibulin 55 gaboxadol 55 Kyrkanides 55 PROactive study 55 comorbid depression 55 ExTRACT TIMI 55 Zivadinov 55 malignant pleural effusion 55 Kaplitt 55 Molly Wagster 55 Farzaneh Far 55 neurocognitive deficits 55 antitumor effects 55 PSMA ADC 55 Pagoclone 55 LC#m# vaccine 55 Decety 55 immune modulating 55 Tony Wyss Coray 55 Fanconi syndrome 55 dalfampridine 55 cardioprotection 54 INSPIRE Trial Phase III 54 receptor inhibitor 54 Weese Mayer 54 venlafaxine Effexor 54 AChE inhibitors 54 pathogenetic mechanisms 54 dopaminergic therapy 54 pathogenic mechanisms 54 citalopram Celexa 54 meta regression 54 OHR/AVR# 54 Alequel 54 CALHM1 54 symptomatic VTE 54 experimental allergic encephalomyelitis 54 methodological limitations 54 benfotiamine 54 ToGA 54 transgenic mouse models 54 Hutchinson Gilford progeria 54 HGS# 54 EDARBI 54 Clusterin 54 Dr. Fombonne 54 antiphospholipid antibodies 54 Mofenson 54 dopamine D1 54 Lambris 54 Nora Volkow director 54 GBA mutations 54 Di Bisceglie 54 Berislav Zlokovic MD Ph.D. 54 PROCHYMAL 54 imexon 54 Eliezer Zomer Ph.D. 54 Amy Abernethy 54 Dr. Gianni Belcaro 54 histone deacetylase inhibitors 54 PLX STROKE targeting 54 EnVivo 54 Disis 54 huC# DM4 54 Arimoclomol 54 imipramine 54 antiresorptive 54 AML MDS 54 safinamide 54 aripiprazole Abilify 54 anti TNFa 54 squamous cell lung cancer 54 vitamin B# folic acid 54 testosterone supplementation 54 Lodamin 54 induced ischemia 54 tacrine 54 RE LY trial 54 NeuroVax 54 debilitating neurodegenerative disorder 54 Nicholas Borys 54 Bergenstal 54 Hesdorffer 54 ACTEMRA TM 54 SYN# 54 PARP inhibition 54 Pericak Vance 54 Zeuzem 54 Michael Leitzmann 54 serotonin reuptake inhibitor 54 dyskeratosis congenita 54 Dr. Maraganore 54 florbetaben 54 hyperalgesia 54 Dr. ATW Simeons 54 neuroleptic 54 Bart De Strooper 54 memantine Namenda 54 pressor response 54 HER2 overexpression 54 JAK inhibitors 54 axonal damage 54 Richard Restak 54 Boden Albala 54 amyloid deposition 54 Jon Kar Zubieta 54 blood clot dissolving 54 HuMax EGFr 54 ginkgo extract 54 Cytolin R 54 prospectively stratified 54 Prostatitis 54 recurrent herpes labialis 54 TRO# 54 RhuDex 54 Monica Mita 54 clinicopathological 54 fluoxetine Prozac 54 Adesman 54 INVEGA ® SUSTENNA ® 54 DDP# 54 intensive statin therapy 54 Rauschecker 54 antiproliferative effects 54 Violari 54 Jorge Cortes MD 54 lymphomas leukemias 54 Morquio 54 Dr. Sackner 54 Stanton Samenow 54 EndoTAGTM 1 54 Rebecca Garten 54 PR interval prolongation 54 QTc prolongation 54 ELACYT 54 LHRH agonists 54 Mechanistic studies 54 morphometric vertebral fractures 54 RSD# oral 54 Polychronakos 54 intermittent dosing 54 redox active 54 Onconase 54 ghrelin leptin 54 allodynia 54 shorter telomere length 54 mTOR inhibition 54 neuroprotective effects 54 VMAT2 54 Kalantar Zadeh 54 Sprycel dasatinib 54 Youdim 54 BEXXAR Therapeutic Regimen 54 prostate carcinogenesis 54 BNC# 54 Ovbiagele 54 Paliperidone ER 54 Olanow 54 FTIs 54 Piomelli 54 TNF blocker therapy 54 BGC# 54 Lixivaptan 54 cerebral microbleeds 54 APEX AMI trial 54 infliximab etanercept 54 Aflibercept 54 MMP inhibitors 54 urate levels 54 serum biomarkers 54 serum estradiol 54 SNT-MC#/idebenone 54 pediatric bipolar disorder 54 neurological abnormalities 54 elotuzumab 54 Paavonen 54 S. maltophilia 54 Newton Cheh 54 tegaserod 54 acetylcholinesterase inhibitor 54 pivotal bioequivalence 54 XMRV infection 54 gastrointestinal dysfunction 53 Inhaled nitric oxide 53 DHEA supplementation 53 Lancet Neurology journal 53 galanin 53 memantine HCl 53 guanfacine 53 ropinirole Requip 53 Buijsse 53 Merikangas 53 Okunieff 53 Skovronsky 53 potentiation 53 idiopathic Parkinson disease 53 INGAP 53 D 1mT 53 Kadan Lottick 53 Relapsing Remitting MS 53 anaphylactic reactions bronchospasm 53 Siliciano 53 Bipolar Disorders 53 PF # [002] 53 Ascherio 53 C1 INH deficiency 53 adenotonsillectomy 53 CCR2 53 zoledronate 53 antidepressant efficacy 53 gamma secretase inhibitor 53 Neuropeptide Y 53 bardoxolone methyl 53 EEG abnormalities 53 Mitochondrial dysfunction 53 oral rivaroxaban 53 anticancer activity 53 CTAP# Capsules 53 Patricia Hartge 53 psychiatric disorders ATI 53 Treat Parkinson Disease 53 cholinesterase inhibitor 53 verteporfin 53 Dr. Gambotto 53 Oreopoulos 53 Dr. Moscona 53 ADPKD 53 Ph.D. XenoPort 53 Van Den Eeden 53 Urocortin 2 53 intracranial hypertension 53 oversulfated version 53 Slatore 53 neuropsychological impairments 53 PON1 activity 53 Imipramine 53 multicenter trials 53 Serdolect ® 53 Stickgold 53 lenalidomide dexamethasone 53 T1DM 53 erythropoietic 53 Surks 53 UCSF Headache Center 53 HMG CoA reductase inhibitors 53 analgesic effects 53 Mr. Rosconi 53 neuropsychiatric diseases 53 anorexia cachexia 53 etomidate 53 intravascular hemolysis 53 lenalidomide Revlimid 53 poststroke 53 Dr. Loprinzi 53 ADVANCE PD 53 retinoid X 53 TNF antagonist 53 MYTHOS trial 53 cortical stimulation 53 coronary calcification 53 Relapsing remitting MS 53 agomelatine 53 myotonic muscular dystrophy 53 SIRT3 53 ACV1 53 lipid lowering therapy 53 William Sandborn MD 53 Lorianne Masuoka MD 53 Zeldox 53 Dr. Merzenich 53 relieving menopausal symptoms 53 Beatrice Golomb 53 Kiecolt Glaser 53 Victor Gambone 53 PRIMO CABG 53 neurologic symptoms 53 Hakon Hakonarson 53 induce orthostatic hypotension 53 Adjuvant therapy 53 Peptide YY 53 AZT zidovudine Retrovir 53 Iloperidone 53 George Ebers 53 Potiga 53 Mipomersen 53 sertraline Zoloft 53 Paul Talalay 53 Georges Gemayel 53 vitamin D inadequacy 53 thyrotropin 53 gepirone ER 53 autonomic dysfunction 53 extrapyramidal symptoms 53 HIV HCV coinfected 53 neurofibrillary 53 Matthew Meyerson 53 Relkin 53 SinuNase ™ 53 Schoppe Sullivan 53 Uyeki 53 malignant lymphomas 53 oral antidiabetes 53 Dr. Victor Velculescu 53 human Chorionic Gonadotropin 53 NP2 Enkephalin 53 F. Holick 53 Bezielle 53 activated microglia 53 ThermoDox ® clinical 53 maintaining cardiorespiratory fitness 53 journal Neuropsychopharmacology 53 cortical atrophy 53 prodromal phase 53 CYP#D# inhibitor 53 hyperphenylalaninemia HPA due 53 behavioral abnormalities 53 SPARCL 53 mitochondrial toxicity 53 modified REGENESIS Phase IIb 53 PU H# 53 anti androgen 53 Fluvastatin 53 angiogenesis inhibition 53 JAK inhibitor 53 STAT3 signaling 53 epigenetic changes 53 Fadel Zeidan 53 Phase IIA 53 Orrin Devinsky MD 53 phase IIa clinical 53 neurosensory 53 elevated ALT 53 subclinical atherosclerosis 53 Electroconvulsive therapy 53 oral dual endothelin 53 Cancer Immunobiology Center 53 Chain Intellect 53 Eric Van Cutsem 53 Newschaffer 53 angiographically 53 Tim Coughlin MAusIMM 53 Mark A. Sirgo 53 avanafil PDE5 inhibitor 53 #q#.# deletion syndrome 53 eritoran 53 Paroxysmal Nocturnal Hemoglobinuria PNH 53 progressive neurodegenerative disorder 53 dose escalation phase 53 Squalamine 53 Miklowitz 53 Schlaggar 53 Prozac fluoxetine 53 Lewis Cantley 53 Bruce Chesebro 53 Cooper DeHoff 53 guanfacine extended release 53 rasagiline mesylate 53 disulfiram 53 schizophrenia CIAS 53 lymphocyte counts 53 developmental neurotoxicity 53 Sina Bavari 53 erlotinib Tarceva 53 Cognitive impairment 53 TMS Therapy 53 Mark Witeck 53 Akira Sawa 53 SSRI antidepressant 53 gabapentin Neurontin 53 Screening Trial DMIST 53 Chronic pancreatitis 53 Pantuck 53 Thase 53 Aggrastat ® tirofiban hydrochloride 53 myelogenous leukemia 53 Myrna Weissman 53 Corus CAD 53 Robert Siliciano 53 Brodmann Area 53 NOMID 53 synaptic function 53 Timothy Rebbeck 53 Mark HN Corrigan 53 Tuomilehto 53 neurocognitive impairment 53 serum BDNF 53 CLA supplementation 53 Diamyd ® 53 Clauw 53 dementia praecox 53 masitinib 52 overactive bladder symptoms 52 T1 weighted images 52 transgenic rats 52 follicular lymphomas 52 latrepirdine 52 Rudolph Tanzi 52 Lisa Mosconi 52 neurotrophic 52 HDL Selective Delipidation 52 mTOR mammalian target 52 mycophenolate mofetil 52 Epidemiologic studies 52 Jurgen Rehm 52 Aplidin 52 neurologic disorder 52 Steven Hatfill bioterrorism 52 reuptake inhibitor 52 lenalidomide Revlimid R 52 Clive Svendsen 52 PEG SN# 52 DFMO 52 coinfected patients 52 Fillit 52 Akathisia 52 Rando Allikmets 52 HPA axis 52 J. Donald deBethizy 52 Dr. Gozal 52 Suicidal ideation 52 Gavin Giovannoni 52 Margolskee 52 maximal doses 52 eosinophilic asthma 52 Enzastaurin 52 subsyndromal 52 anthracyclines taxanes 52 Wernicke Korsakoff syndrome 52 Talabostat 52 neuropathic pain spasticity 52 Saykin 52 Omenn 52 Rimoin 52 Avandia Actos 52 pemetrexed Alimta 52 post herpetic 52 Hacksell 52 Dr. Arndt Schottelius 52 Triapine R 52 inecalcitol 52 tramiprosate Alzhemed TM 52 paroxetine Seroxat 52 Atomoxetine 52 Leon Thal 52 Paliperidone 52 Vlachopoulos 52 Harousseau 52 idiopathic thrombocytopenic purpura 52 Ocrelizumab 52 herpes zoster vaccine 52 alpha synuclein gene 52 serotonin imbalance 52 dexpramipexole 52 antidepressants fluoxetine 52 Mantzoros 52 bezafibrate 52 activate AMPK 52 canakinumab 52 paroxetine sertraline 52 Phase 1a clinical 52 Timothy Botello 52 bronchopulmonary dysplasia 52 spermidine 52 brain lesions 52 Research www. elsevier.com 52 genetic locus 52 Victor Velculescu 52 Mukamel 52 CURE AF 52 Manfred Kayser 52 Dangour 52 Cyclin E 52 Barbara Sahakian 52 Alan Kingsman 52 lomitapide 52 Endocrine Society #st 52 atypical neuroleptics 52 Mootha 52 Kaptchuk 52 quinacrine 52 tasimelteon 52 Nora D. Volkow 52 Froguel 52 Ruvkun 52 familial clustering 52 methotrexate therapy 52 status epilepticus 52 hepatotoxicity 52 clinically meaningful improvement 52 galantamine 52 alvespimycin 52 beta1 integrin 52 forodesine 52 beta 1a 52 Fulvestrant 52 Mr. Mordock 52 platelet dysfunction 52 bicalutamide 52 Traficet EN 52 radezolid 52 olanzapine quetiapine 52 metaanalysis 52 Tasigna prolongs 52 microRNA expression 52 Parkinson Disease PD 52 Stanley Fahn 52 ziprasidone Geodon 52 Daniel Von Hoff 52 Hertzel Gerstein 52 BRCA testing 52 Kissela 52 flecainide 52 TGen Neurogenomics Division 52 postmenopausal hormones 52 Thomas Südhof 52 HuLuc# 52 Parnia 52 myeloproliferative disorders 52 Gutmann MD Ph.D. 52 narcolepsy cataplexy 52 GRNOPC1 contains 52 HBV infections 52 Shaywitz 52 pouchitis 52 Scarmeas 52 DePinho 52 subclinical hyperthyroidism 52 Kandzari 52 Mechoulam 52 haemorrhagic strokes 52 phase IIa 52 journal Neuropsychologia 52 Guoping Feng 52 Kaeberlein 52 mitoxantrone plus 52 #q# deletion syndrome 52 lipid lowering therapies 52 glutamic acid decarboxylase 52 Jonas Frisen 52 Etanercept 52 MMP inhibitor 52 budesonide foam 52 Sackner Bernstein 52 Dr. Fahar Merchant 52 Mg Uk 52 genetic polymorphisms 52 enzastaurin 52 CIPN 52 bipolar illness 52 Enobia 52 prazosin 52 pentoxifylline 52 pegylated liposomal doxorubicin 52 Gangwisch 52 ginkgo biloba extract 52 aminotransferases 52 intravenous CK # 52 inhibit metastasis 52 alemtuzumab treated 52 Nigrovic 52 SE5 OH containing 52 ibudilast 52 NOD mouse 52 serotonin reuptake inhibitors SSRIs 52 EMPOWER ™ 52 rindopepimut 52 nalbuphine ER 52 SUTENT ® 52 REMINYL ® 52 PTHrP 52 Nora Volkow 52 Gaboxadol 52 Joseph Loscalzo 52 amyloid beta plaque 52 seropositivity 52 HeFH 52 Muraglitazar 52 monoinfected patients 52 LATUDA 52 Intravenous immunoglobulin 52 immune modulatory 52 retrovirus XMRV 52 SCD1 52 SHANK3 gene 52 neurodevelopmental disability 52 Nephrology Dialysis Transplantation 52 Nordestgaard 52 adrenergic regulation 52 Izpisúa Belmonte 52 primidone 52 apolipoprotein A1 52 GGF2 52 Frits Rosendaal 52 electroencephalographic 52 Trasande 52 Ellen Vitetta 52 AZILECT ® 52 Alzheimer Disease AD 52 Dr. McHutchison 52 QTc intervals 52 magnetic stimulation 52 IGF 1R inhibitor 52 alpha#beta# 52 aMCI precursor 52 argatroban 52 androgen suppression 52 Markus Heilig 52 Alzheimer disease cognitive impairment 52 Mikovits 52 5 HT1A 52 androgen depletion therapy 52 intravenous bisphosphonates 52 GW# [003] 52 acadesine 52 synthetic lethality 52 Angela Genge 52 demethylating agents 52 efalizumab 52 antidepressive 52 PPARγ 52 teriflunomide 52 neuropeptide Y 52 Weimbs 52 Limperopoulos 52 Ruschitzka 52 Timothy Salthouse 52 Dr. Madhukar Trivedi 52 CANCIDAS 52 PORxin TM platforms 52 adalimumab Humira 52 Dr. Tobias Kurth 52 clinically meaningful improvements 52 Cortisol levels 52 DMIST 52 IRX 2 52 proteasome inhibition 52 Faerstein 52 renal toxicity 52 Joshua Boger Ph.D. 52 Hepatocellular Carcinoma HCC 52 Dr. Coppari 52 tranylcypromine 52 NATRECOR R 52 Tollefsbol 52 Lynda Chin 52 aneurysmal subarachnoid hemorrhage 52 Chimowitz 52 anthracycline chemotherapy 52 coronary artery atherosclerosis 52 HIF PHI 52 acute psychosis 52 hereditary deficiency 52 longitudinal observational study 52 Helen Mayberg 52 experimentally induced 52 ACZ# 52 Margaret Gatz 52 somatostatin 52 pharmacokinetic PK study 52 moderately heritable 52 PCNSL 52 statistically significant efficacy 52 cognitively normal 52 Cethromycin 52 Aviptadil 51 bacterial prostatitis 51 Empatic ™ 51 gp# vaccine 51 Quay MD Ph.D. 51 tubulin inhibitor 51 cilostazol 51 precursor mild cognitive 51 dysbindin gene 51 Sharlip 51 flutamide 51 Michael Kaplitt 51 Simone Shamay Tsoory 51 ADAS Cog 51 Panzem 51 BZA CE 51 Velcade bortezomib 51 dexanabinol 51 SNS# T 51 Dr. Bezprozvanny 51 de novo mutations 51 Johan Auwerx 51 ThGRF 51 journal Neuropsychology 51 paliperidone ER 51 Ryuji Ueno 51 INTEGRILIN 51 prodromal symptoms 51 TIMP 1 51 neuropsychological deficits 51 Mayo Clinic rheumatologist 51 #mg dose [002] 51 Kathleen Merikangas 51 Dr. Rafii 51 Goldbach Mansky 51 RSD# 51 anxiolytic 51 adrenal suppression 51 Thrombotic events 51 antiseizure medication 51 Richard Wurtman 51 Dolores Malaspina 51 Clay B. Siegall 51 rFVIIa 51 chronic granulomatous disease 51 oral mTOR inhibitor 51 NAbs 51 Manuelidis 51 Tranexamic acid 51 Dacogen decitabine 51 clobazam 51 TIMI Study Group 51 Shiekhattar 51 IMA# 51 Rachel Manber 51 spirometric 51 parasomnias 51 noscapine 51 tasocitinib 51 syncopal episode 51 hepatic toxicity